https://doi.org/10.1097/jto.0b013e318206a221
A
Adi F. Gazdar
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
1.2K
Papers
114.8K
Citations
161
h-index
602
i10-index
Adi F. Gazdar is an academic researcher from Weatherford College. The author has contributed to research in topics: Lung Cancer Treatments and Mutations & RNA modifications and cancer & Lung Cancer Research Studies. The author has an h-index of 161, co-authored 1054 publications.
ORCID: 0000-0002-5718-247XPapers by this author
worksInternational Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma
2011 · Journal of Thoracic Oncology · 4,773 citations
<i>MET</i> amplification occurs with or without <i>T790M</i> mutations in <i>EGFR</i> mutant lung tumors with acquired resistance to gefitinib or erlotinib
2007 · Proceedings of the National Academy of Sciences · 1,582 citations
https://doi.org/10.1073/pnas.0710370104
A small-cell lung cancer genome with complex signatures of tobacco exposure
2009 · Nature · 1,060 citations
https://doi.org/10.1038/nature08629
SOX2 is an amplified lineage-survival oncogene in lung and esophageal squamous cell carcinomas
2009 · Nature Genetics · 944 citations
https://doi.org/10.1038/ng.465
MYC Drives Progression of Small Cell Lung Cancer to a Variant Neuroendocrine Subtype with Vulnerability to Aurora Kinase Inhibition
2017 · Cancer Cell · 591 citations
https://doi.org/10.1016/j.ccell.2016.12.005
ASCL1 and NEUROD1 Reveal Heterogeneity in Pulmonary Neuroendocrine Tumors and Regulate Distinct Genetic Programs
2016 · Cell Reports · 519 citations
https://doi.org/10.1016/j.celrep.2016.06.081
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat